Topical BioMedics gains national distribution for Topricin Foot Therapy Cream
RHINEBECK, N.Y. — Topical BioMedics recently announced distribution through CVS/pharmacy for its Topricin Foot Therapy Cream, a homeopathic topical treatment for pain associated with fibromyalgia and neuropathy that is safe for diabetics.
“We are delighted that Topricin Foot Therapy Cream has been chosen by CVS for inclusion in its foot care section,” stated Lou Paradise, Topical BioMedics’ president and chief of research. “It is estimated that more than 20 million Americans suffer from neuropathy, and 60% of all diabetic patients experience neuropathy in their feet, which can be painfully debilitating and greatly impacts their quality of life. Because our formula is patented for the treatment of pain associated with neuropathy, it offers a safe, effective option for people suffering from both diabetic and chemo-induced neuropathy."
Topricin Foot Therapy Cream has been specially formulated to address pains associated with foot and ankle pain and injuries, including gout, heel spurs, bunions and such sports injuries as Plantar fasciitis, Achilles tendonitis and shin splints, as well as neuropathic pain, the company reported.
Fuse Science launches ad campaign supporting Powered By Fuse energy products
MIAMI LAKES, Fla. — Fuse Science on Monday announced that as of late last month it has officially launched its ad campaign behind Powered By Fuse energy products.
"We are now firmly in the roll-out of our commercial advertising and encouraged by initial responses to the Powered By Fuse message," stated Brian Tuffin, CEO Fuse Science. "In addition, we are currently shipping new display units to participating Duane Reade locations which is part of our continued expansion of our distribution footprint and supported by a series of new commercial and print ads that are designed to drive product trial and repeat purchase while leveraging our world-class athletes."
Celebrity endorsers include pro golfing legend Tiger Woods, Boston Red Sox hitter David Ortiz and one of the judges on "Shark Tank," Daymond John.
Smith Bros. making comeback in lozenge space
NEW YORK — Represented by the Greenwood Group, Smith Brothers is making its way back onto shelves with a new way of thinking about sore throat lozenges, according to a report published Friday by Bloomberg.
According to the report, Smith Brothers was bought out of bankruptcy in 2010 by York Capital Management and is in the process of introducing new products that include Night Time drops with melatonin and chamomile to aid sleep, as well as electrolyte-laced Restore lozenges to help re-energize people.
The company is headed by CEO Steven Silk, who is bringing a focus on health and wellness to the brand, according to the report.